Intercos (ICOS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved record Q2 2024 with net sales of €278.9M–€279M (+9.9%–10% YoY) and Adjusted EBITDA of €43.2M (+15% YoY), offsetting most Q1 cyber attack impacts.
H1 2024 net sales reached €499.9M (+2.4% YoY), with Adjusted EBITDA at €64M (-5% YoY), reflecting Q1 disruption.
Order book at end of June up 12.5%–13% YoY, with strong order entry and increased exposure to prestige customers.
Awarded EcoVadis Platinum medal for ESG for third consecutive year, ranking in the top 1% of the sector.
Expansion underway in Korea and China, with new commercial/research presence in India.
Financial highlights
Q2 net sales: €278.9M–€279M (+9.9%–10% YoY); minimal FX headwind (-30bps).
Q2 Adjusted EBITDA: €43.2M (+15% YoY, margin 15.5%); H1 Adjusted EBITDA margin: 12.8% (down 99bps YoY).
H1 adjusted net income: €22.9M (-14.9% YoY); H1 net income: €17.9M (-28.5% YoY).
H1 operating cash flow: €23.2M, up €15.7M–€16M YoY; improved working capital management.
Net debt at June 30, 2024: €114M–€114.1M, leverage ratio at 0.85x EBITDA.
Outlook and guidance
FY24 guidance confirmed: full-year sales growth expected at +6%–8%, with H2 sales projected to rise 10%–13% YoY.
Strong order book and balanced product mix support confidence for double-digit H2 growth.
EMEA and Asia expected to remain robust; Americas may recover in H2 despite market volatility.
H2 EBITDA margin expected in the 15%–15.5% range, similar to Q2.
Latest events from Intercos
- Record profitability and margin expansion achieved in 2025; growth expected in 2026.ICOS
Q4 20254 Mar 2026 - Adjusted EBITDA up 12.3% in 9M25, with Make-up driving growth and margin improvement.ICOS
Q3 20253 Feb 2026 - Q3 sales and EBITDA up over 12%, driven by Asia and EMEA, with margin pressure ongoing.ICOS
Q3 202416 Jan 2026 - 2024 sales up 8% to €1.06bn, EBITDA up 4.3%, and 2025 growth guided at 5–7%.ICOS
Q4 20242 Dec 2025 - Q1 2025 sales up 13.4% and EBITDA up 40.6%, driven by Make-up and multinational demand.ICOS
Q1 202526 Nov 2025 - Strong H1 sales and margin gains led by Make-up, despite currency and Hair & Body headwinds.ICOS
Q2 202523 Nov 2025